• BioNTech's Richardson on Drug Pipeline

  • Oct 3 2024
  • Length: 38 mins
  • Podcast

BioNTech's Richardson on Drug Pipeline

Listen for free

View show details

  • Summary

  • BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who explains the company’s approach to drug development, hopes for drug launches and what sets it apart from rivals.

    See omnystudio.com/listener for privacy information.
    Show More Show Less
Hygiene & Healthy Living Economics Personal Finance
Show More Show Less
activate_samplebutton_t1

What listeners say about BioNTech's Richardson on Drug Pipeline

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.